PICan: An integromics framework for dynamic cancer biomarker discovery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Oncology

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1016/j.molonc.2015.02.002PMID 25814194PMCID PMC5528750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PICan: An integromics framework for dynamic cancer biomarker discovery

  2015cited by this paper
• gplots: Various R Programming Tools for Plotting Data

  2015cited by this paper
• Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ

  2014cited by this paper
• Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer

  2014cited by this paper
• Molecular pathology – The value of an integrative approach

  2014cited by this paper
• iGPSe: A visual analytic system for integrative genomic based cancer patient stratification

  2014cited by this paper
• The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer

  2014cited by this paper
• Principles and methods of integrative genomic analyses in cancer

  2014cited by this paper
• Identifying survival associated morphological features of triple negative breast cancer using multiple datasets

  2013cited by this paper
• A colorectal cancer classification system that associates cellular phenotype and responses to therapy

  2013cited by this paper
• TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data

  2013cited by this paper
• Visualizing multidimensional cancer genomics data

  2013cited by this paper
• Harvest: an open platform for developing web-based biomedical data discovery and reporting applications

  2013cited by this paper
• Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

  2012cited by this paper
• Systematic identification of genomic markers of drug sensitivity in cancer cells

  2012cited by this paper
• The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

  2012cited by this paper
• pROC: an open-source package for R and S+ to analyze and compare ROC curves

  2011cited by this paper
• Frozen robust multiarray analysis (fRMA).

  2010cited by this paper
• integrOmics: an R package to unravel relationships between two omics datasets

  2009cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• Data integration: challenges for drug discovery

  2005cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper

• Predictive biomarkers for personalized medicine in breast cancer.

  2022cites this paper
• Deep Learning Model as a New Trend in Computer-aided Diagnosis of Tumor Pathology for Lung Cancer

  2020cites this paper
• Health Vision: An interactive web based platform for healthcare data analysis and visualisation

  2019cites this paper
• Towards visualizing primary Sjögren's Syndrome data from heterogeneous cohorts

  2018cites this paper
• Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer

  2017cites this paper
• Morphomolecular pathology: setting the framework for a new generation of pathologists

  2017cites this paper
• Time for change: a new training programme for morpho-molecular pathologists?

  2017cites this paper
• Cancer Critical Research Gaps in Colorectal Cancer Initiative (2018). Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in

  2017cites this paper
• Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer

  2016cites this paper
• Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned

  2016cites this paper
• Building a 'Repository of Science': The importance of integrating biobanks within molecular pathology programmes.

  2016cites this paper
• Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer

  2016cites this paper
• QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

  2016cites this paper
• PICan: An integromics framework for dynamic cancer biomarker discovery

  2015cites this paper
• Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

  2015cites this paper
• Automated tumor analysis for molecular profiling in lung cancer

  2015cites this paper